Torrent Pharma reports strong Q3 earnings and JB Pharma acquisition
after close1 source ↓written by the desknot a recommendation
- in Q3 FY26
- 17.6% YoY increase
Torrent Pharmaceuticals reported consolidated revenue of ₹3,303 cr, a 17.6% YoY increase in Q3 FY26, driven by the JB Pharma acquisition. Net profit surged 26.2% YoY to ₹635 cr, reflecting robust operational performance. The stable EBITDA margin at 33% indicates effective cost management, enhancing investor sentiment.
Not investment advice. For informational purposes only.